Who Signs Argentina's Peptide Declaration?

The sworn declaration attached to a peptide shipment entering Argentina is signed by whoever is named as the consignee — the importer — or by the licensed customs broker (*despachante de aduana*) acting on that person's behalf before Argentine Customs. It is not signed by the foreign supplier who ships the package. What the supplier provides is a different document: commercial paperwork describing exactly what the contents are, so the person receiving the shipment can declare it accurately.

This distinction gets muddled because, in everyday conversation, "the sworn declaration" and "the shipment's paperwork" sound like the same thing. They are not, and it is worth separating them before anything ships or arrives.

What the exporter signs, and what the importer signs

The supplier — in this case, whoever ships the material from abroad — issues the commercial invoice: the document describing what is being sent, in what quantity, and at what declared value. That invoice travels with the package and is the basis for everything that follows, but it is a document from the seller, not a sworn statement made to another country's customs authority.

The sworn declaration, by contrast, is an act performed by the importer. It is that person — or the customs broker representing them, when the transaction requires one — who becomes legally responsible for what the declaration says about the contents once the shipment crosses into Argentina. That is not a minor formality: it is the reason the description on the commercial invoice has to be precise and verifiable, because the importer is the one who ends up standing behind it.

For lower-value shipments handled through the mail or a courier, the process is usually resolved with simplified documentation and no broker involved. For larger shipments, or when the applicable import regime requires it, a licensed customs broker steps in and signs the declaration on the importer's behalf, using the paperwork the supplier provided.

What documentation PeptoClinic prepares for each Argentina shipment

PeptoClinic puts together the file for each shipment so that whoever receives it in Argentina has what they need to declare without ambiguity. That includes:

• A commercial invoice with an exact description of the contents: compound, format and quantity.
• The lot's certificate of analysis (COA), when one has been published for that compound, so the description doesn't rest on an unsupported claim.
• An explicit statement that the material is supplied as Research Use Only (RUO) laboratory reference material — not a product for human or veterinary consumption.

That third point matters more than it might seem. A shipment clearly declared as research material is treated differently, in terms of which regime applies to it, than a shipment presented as a pharmaceutical or consumer product. Ambiguity in the description doesn't help anyone: it complicates the process regardless of who ultimately signs. Details of routing and the destinations currently quoted live on the shipping page.

Why the description matters as much as the signature

The fact that the importer applies the signature doesn't mean the supplier's responsibility ends once the package leaves. A vague description — or worse, one that doesn't match what actually travels inside the package — forces the person receiving the shipment to declare based on information they don't control. That's backwards from how it should work: the documentation is supposed to support the declaration, not create a problem for whoever signs it.

That's why every lot quoted for an Argentine destination is accompanied, when one exists, by the report from the laboratory that analyzed it. It is a third-party document — not a claim PeptoClinic makes about its own product — and it is what keeps the invoice's description from depending on blind trust. How to read that report, and which laboratory issues it, is explained on the quality page.

The material is for laboratory research, not for consumption

Everything quoted in the catalogue is supplied strictly as reference material for in vitro and laboratory research. It is not a medicine, not a supplement, not a food, and it is not approved or evaluated for human or veterinary use, diagnosis or treatment of any condition. No prescription is issued or required, and no consultation on this site includes administration guidance, dosing or a protocol intended for a person. That boundary shapes both the shipment documentation and the entire catalogue.

Which compounds most often travel with this file

The compounds that generate the most inquiries for Argentine destinations are the ones with a published laboratory report and their own country page, such as retatrutide, MOTS-c and GHK-Cu. In each of those cases, the shipping file is built with the same criteria: exact compound name, format, quantity, and the lot's report when one exists. The full catalogue, along with what is currently quoted for the Argentine market, is on the Argentina destination page.

What happens when the declaration doesn't match the contents

A declaration that doesn't match what actually arrives in the package — whether from an incomplete description, a mis-entered value, or an omission — is the responsibility of whoever signed it, which in most cases is the importer or their broker. That is another reason the precision of the commercial invoice the supplier provides is not an administrative detail: it is the material the other party will have to rely on when answering to Customs.